We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$306M
AUM Growth
+$1.16M
Cap. Flow
+$5.53M
Cap. Flow %
1.81%
Top 10 Hldgs %
73.79%
Holding
69
New
7
Increased
1
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
GTM
ZoomInfo Technologies
GTM
+$11.6M
2
PAYO icon
Payoneer
PAYO
+$2.44M
3
PLRX icon
Pliant Therapeutics
PLRX
+$1.24M
4
RVMD icon
Revolution Medicines
RVMD
+$968K
5
SMRT icon
SmartRent
SMRT
+$869K

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$6.81M
2
WMS icon
Advanced Drainage Systems
WMS
+$4.05M
3
BE icon
Bloom Energy
BE
+$1.35M

Sector Composition

Rank Sector Weight
1 Technology 61.39%
2 Healthcare 16.59%
3 Consumer Discretionary 14.46%
4 Communication Services 2.3%
5 Financials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGTX
51
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$374K 0.12%
56,980
– –
GTLB icon
52
GitLab
GTLB
$5.7B
$317K 0.1%
+6,183
New +$361K
MCRB icon
53
Seres Therapeutics
MCRB
$46.3M
$317K 0.1%
2,468
– –
IPSC icon
54
Century Therapeutics
IPSC
$395M
$287K 0.09%
29,018
+14,387
+98% +$152K
QS icon
55
QuantumScape Corp
QS
$3.22B
$243K 0.08%
28,951
– –
LOV
56
DELISTED
Spark Networks SE American Depositary Shares
LOV
$199K 0.07%
104,228
– –
DCT
57
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$172K 0.06%
14,508
– –
RPTX
58
DELISTED
Repare Therapeutics
RPTX
$149K 0.05%
12,276
– –
OPEN icon
59
Opendoor
OPEN
$3.69B
$145K 0.05%
48,264
– –
PMVP icon
60
PMV Pharmaceuticals
PMVP
$60.3M
$137K 0.04%
11,533
– –
PACB icon
61
Pacific Biosciences
PACB
$460M
$136K 0.04%
23,484
– –
DASH icon
62
DoorDash
DASH
$86.1B
$124K 0.04%
2,505
– –
ASTR
63
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$114K 0.04%
12,444
– –
GRNA
64
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$113K 0.04%
+48,835
New +$128K
OYST
65
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$71K 0.02%
12,560
– –
NXTC icon
66
NextCure
NXTC
$20.5M
$28K 0.01%
837
– –
ALGS icon
67
Aligos Therapeutics
ALGS
$26.7M
$21K 0.01%
751
– –
WMS icon
68
Advanced Drainage Systems
WMS
$10.5B
– –
-44,990
Closed -$4.05M
HCP
69
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-231,288
Closed -$6.81M
1 2
3

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Harbourvest Partners held 69 positions worth $306M, up 0.38% from $305M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Harbourvest Partners's Q3 2022 filing shows 7 new, 1 increased, 1 reduced and 2 closed positions. Its largest new stake was ZoomInfo Technologies: 272,572 shares worth $11.4M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $6.81M.

By sector, the portfolio is most concentrated in Technology at 61% of assets, up from 57% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Harbourvest Partners's largest Q3 2022 buy was ZoomInfo Technologies: 272,572 shares worth $11.4M.
  • Harbourvest Partners added most to Century Therapeutics in Q3 2022, an estimated $152K increase.
  • Harbourvest Partners's biggest Q3 2022 reduction was Bloom Energy, cutting an estimated $1.35M.
  • Harbourvest Partners fully exited HashiCorp, Inc. Class A Common Stock in Q3 2022, selling an estimated $6.81M.
  • Harbourvest Partners's ten largest holdings make up 74% of its $306M portfolio in Q3 2022.
  • Harbourvest Partners opened 7 new positions and closed 2 in Q3 2022.
  • Harbourvest Partners's portfolio value rose 0.38% quarter-over-quarter to $306M.

Based on Harbourvest Partners's 13F filing for Q3 2022, filed 14 Nov 2022.